explore -WSS

explore

author：comprehensive 2025-09-27 16:36:23 - browse：656

Photograph of Ron DeSantis pointing. -- health policy coverage from STAT — Florida Gov. and GOP presidential candidate Ron DeSantis wants to import Canadian prescription drugs. Charlie Neibergall/AP

WASHINGTON — Florida governor and presidential hopeful Ron DeSantis has ballyhooed a high-profile plan to import prescription drugs from Canada, even suing the Biden administration for allegedly holding up a necessary sign-off.

But the plan’s long odds just got longer: the Food and Drug Administration said in a letter last week that Florida’s plan has gaping holes — and the state has less than a week to explain how it’ll fix them.

The FDA “identified several deficiencies,” in the drug-import plan, it said. Despite its thousands of pages, the plan does not show whether it meets the two overarching requirements of saving money and securing the drug supply chain, the agency explained. The FDA gave the state until August 28 to flesh out those two subjects.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Feds fine Medicare Advantage plans for overcharging members

WSS

Departing Stanford president retracts two papers

In science, is the line between industry and academia shifting?

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Psilocybin's anti

STAT Summit: The economic case for universal basic health care

knowledge

explore

focus

Peter Hotez and the public health issue of online harassment

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Walensky prepares to leave CDC — and Congress — behind

AstraZeneca bets AAV gene therapy will still deliver the goods

FDA approval of Sarepta Duchenne genetic therapy gives me hope

2024 GOP presidential candidates spar over abortion in debate

Duchenne breakthrough therapy leaves behind pioneering families

STAT Summit: How researchers deal with rejection

Hollywood unions extend contract negotiations for actors

Study on Amgen’s bispecific immunotherapy produces positive data

focus

FDA panel gives mixed vote on blood pressure devices

What do new weight loss drugs mean for bariatric surgery?

CZI to create biohub to build anti

Diversity in medical illustrations gets boost from Chidiebere Ibe

Drug firms test therapies to halt Alzheimer’s before symptoms arise

AstraZeneca challenges Medicare drug negotiation program

explore

Wikipedia

explore

focus